Reproducibility and Sex Differences in a STZ–High-Fat Diet Model of MASLD and Early Hepatocarcinogenesis
International Journal of Molecular Sciences · 01.04.2026 · 27 (7) · 3200
DOI: 10.3390/ijms27073200 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.04.2026. Verfasst von Marleigh Hefner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Obesity and Metabolic Health Laboratory, Department of Nutritional Sciences, Texas Tech University, Lubbock, TX 79409, USA. Hauptthemen laut MEDLINE: Diet, High-Fat, Non-alcoholic Fatty Liver Disease, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: College of Health and Human Sciences, College of Health and Human Sciences, Texas Tech University.
Abstract (Originalsprache)
Primary liver cancer, particularly hepatocellular carcinoma (HCC), remains a major global health burden, ranking as the fifth most common cancer and the third leading cause of cancer-related mortality worldwide. The rising incidence of HCC is closely linked to metabolic comorbidities, including non-alcoholic fatty liver disease (NAFLD), underscoring the need for improved diagnostic and therapeutic strategies. NAFLD can progress to metabolic dysfunction-associated steatohepatitis (MASH), characterized by inflammation and fibrosis, which markedly increases HCC risk, especially in individuals with obesity and type 2 diabetes (T2D). NAFLD has recently been redefined as metabolic dysfunction-associated steatotic liver disease (MASLD) to better reflect its metabolic basis. However, robust experimental models to study the progression from MASLD to MASH and ultimately HCC remain limited. This proof-of-concept study investigates sex-specific effects of metabolic dysregulation using the STAM (STelic Animal Model; streptozotocin and high-fat diet) mouse model, which recapitulates key features of human MASH and HCC. Neonatal C57BL/6J mice received streptozotocin to induce T2D-like symptoms followed by a high-fat diet. Streptozotocin (STZ) treated mice showed reduced body fat, lower insulin levels, impaired glucose tolerance, and increased expression of genes linked to inflammation, lipid metabolism, and apoptosis. These findings support the STAM model’s utility for MASLD research and highlight the importance of sex-specific strategies to limit HCC progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Obesity and Metabolic Health Laboratory, Department of Nutritional Sciences, Texas Tech University, Lubbock, TX 79409, USA.
ORCID-Profile: Marleigh Hefner, Vijay Hegde
Förderung
- College of Health and Human Sciences
- College of Health and Human Sciences, Texas Tech University
Zitieren
APA
Hefner, M., Hia, R. A., Nguyen, T., Nateqi, M., Dhurandhar, N. V., & Hegde, V. (2026). Reproducibility and Sex Differences in a STZ–High-Fat Diet Model of MASLD and Early Hepatocarcinogenesis. International Journal of Molecular Sciences, 27(7), 3200. https://doi.org/10.3390/ijms27073200
Vancouver
Hefner M, Hia RA, Nguyen T, Nateqi M, Dhurandhar NV, Hegde V. Reproducibility and Sex Differences in a STZ–High-Fat Diet Model of MASLD and Early Hepatocarcinogenesis. International Journal of Molecular Sciences. 2026;27(7):3200. doi:10.3390/ijms27073200
BibTeX
@article{Hefner2026,
author = {Hefner, Marleigh and Hia, Raksa Andalib and Nguyen, Tiffany and Nateqi, Masoud and Dhurandhar, Nikhil V and Hegde, Vijay},
title = {Reproducibility and Sex Differences in a STZ–High-Fat Diet Model of MASLD and Early Hepatocarcinogenesis},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {3200},
doi = {10.3390/ijms27073200}
}
EUVIMED